Sander S. Florman

Last updated

Sander S. Florman
Alma mater Brandeis University, University of Louisville, Tulane University
Scientific career
Fields transplant surgery
Institutions The Mount Sinai Hospital

Sander S. Florman is an American transplant surgeon and Director of the Recanati/Miller Transplantation Institute at The Mount Sinai Hospital in New York City. He is a member of the American Society of Transplant Surgeons, the American Hepato-Pancreato-Biliary Association, the American Society of Transplantation and the American College of Surgeons. [1] [2]

Contents

Florman's work as the Director of the Transplant Institute at Tulane University in New Orleans earned him recognition as one of New Orleans Magazine's "People to Watch". He was twice named "Health Care Hero" by New Orleans CityBusiness (in 2007 and 2009) and was chosen as one of Gambit Weekly's "40 Under 40" in their "Best of New Orleans" class of 2004. [3] [4] [5] He was recognized by Louisiana Life magazine as one of Louisiana's "Top Doctors" and "Best Doctors" in 2007–2009. [6] Various awards include the Kremetz Resident Research Award, the ASTS Vanguard Prize and Tulane University's Promise in Research Award.

Florman is the author of nine book chapters and more than 75 publications.

Biography

Florman graduated cum laude with honors from Brandeis University with a degree in philosophy. He received his medical degree from the University of Louisville School of Medicine in 1994. He did general surgery training at the Tulane University School of Medicine in New Orleans, also spending a year in the Liver Transplant Lab at The Mount Sinai Medical Center in New York City, where he investigated the effects of hypernatremia in brain death and ischemia/reperfusion injury in liver transplantation. [7] He was recognized as Resident of the Year at Charity Hospital in 1998 and was named Administrative Chief Resident in 1999.

Florman completed a fellowship in multi-organ transplantation and hepatobiliary surgery at Mount Sinai, after which he returned to Tulane University as the Director of Transplantation. He was then named the Director of the Abdominal Transplant Institute [8] and the Director of Transplantation at Children's Hospital of New Orleans.

He was named Director of Mount Sinai's Recanati/Miller Transplantation Institute in October 2009.

Awards

Select publications

Related Research Articles

<span class="mw-page-title-main">Organ transplantation</span> Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

<span class="mw-page-title-main">Caroli disease</span> Medical condition

Caroli disease is a rare inherited disorder characterized by cystic dilatation of the bile ducts within the liver. There are two patterns of Caroli disease: focal or simple Caroli disease consists of abnormally widened bile ducts affecting an isolated portion of liver. The second form is more diffuse, and when associated with portal hypertension and congenital hepatic fibrosis, is often referred to as "Caroli syndrome". The underlying differences between the two types are not well understood. Caroli disease is also associated with liver failure and polycystic kidney disease. The disease affects about one in 1,000,000 people, with more reported cases of Caroli syndrome than of Caroli disease.

<span class="mw-page-title-main">Liver transplantation</span> Type of organ transplantation

Liver transplantation or hepatic transplantation is the replacement of a diseased liver with the healthy liver from another person (allograft). Liver transplantation is a treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. The most common technique is orthotopic transplantation, in which the native liver is removed and replaced by the donor organ in the same anatomic position as the original liver. The surgical procedure is complex, requiring careful harvest of the donor organ and meticulous implantation into the recipient. Liver transplantation is highly regulated, and only performed at designated transplant medical centers by highly trained transplant physicians and supporting medical team. The duration of the surgery ranges from 4 to 18 hours depending on outcome. Favorable outcomes require careful screening for eligible recipient, as well as a well-calibrated live or cadaveric donor match.

<span class="mw-page-title-main">Cholecystectomy</span> Surgical removal of the gallbladder

Cholecystectomy is the surgical removal of the gallbladder. Cholecystectomy is a common treatment of symptomatic gallstones and other gallbladder conditions. In 2011, cholecystectomy was the eighth most common operating room procedure performed in hospitals in the United States. Cholecystectomy can be performed either laparoscopically, or via an open surgical technique.

<span class="mw-page-title-main">Biliary atresia</span> Medical condition

Biliary atresia, also known as extrahepatic ductopenia and progressive obliterative cholangiopathy, is a childhood disease of the liver in which one or more bile ducts are abnormally narrow, blocked, or absent. It can be congenital or acquired. It has an incidence of one in 10,000–15,000 live births in the United States, and a prevalence of one in 16,700 in the British Isles. Biliary atresia is most common in East Asia, with a frequency of one in 5,000.

<span class="mw-page-title-main">Primary biliary cholangitis</span> Autoimmune disease of the liver

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis. Further slow damage to the liver tissue can lead to scarring, fibrosis, and eventually cirrhosis.

<span class="mw-page-title-main">Klatskin tumor</span> Medical condition

A Klatskin tumor is a cholangiocarcinoma occurring at the confluence of the right and left hepatic bile ducts. The disease was named after Gerald Klatskin, who in 1965 described 15 cases and found some characteristics for this type of cholangiocarcinoma

<span class="mw-page-title-main">Cholangiocarcinoma</span> Bile duct adenocarcinoma

Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. Symptoms of cholangiocarcinoma may include abdominal pain, yellowish skin, weight loss, generalized itching, and fever. Light colored stool or dark urine may also occur. Other biliary tract cancers include gallbladder cancer and cancer of the ampulla of Vater.

Hepatectomy is the surgical resection of the liver. While the term is often employed for the removal of the liver from a liver transplant donor, this article will focus on partial resections of hepatic tissue and hepatoportoenterostomy.

<span class="mw-page-title-main">Congestive hepatopathy</span> Medical condition

Congestive hepatopathy, is liver dysfunction due to venous congestion, usually due to congestive heart failure. The gross pathological appearance of a liver affected by chronic passive congestion is "speckled" like a grated nutmeg kernel; the dark spots represent the dilated and congested hepatic venules and small hepatic veins. The paler areas are unaffected surrounding liver tissue. When severe and longstanding, hepatic congestion can lead to fibrosis; if congestion is due to right heart failure, it is called cardiac cirrhosis.

<span class="mw-page-title-main">Hepatoportoenterostomy</span>

A hepatoportoenterostomy or Kasai portoenterostomy is a surgical treatment performed on infants with Type IVb choledochal cyst and biliary atresia to allow for bile drainage. In these infants, the bile is not able to drain normally from the small bile ducts within the liver into the larger bile ducts that connect to the gall bladder and small intestine.

Surgical Outcomes Analysis & Research, SOAR, is a research laboratory of the Department of Surgery at Boston University School of Medicine and Boston Medical Center with expertise in outcomes research. SOAR investigates surgical diseases and perioperative outcomes. The group focuses on pancreatic cancer, other gastrointestinal and hepatobiliary malignancies, vascular disease, and transplant surgery. SOAR's goal is to examine quality, delivery, and financing of care in order to have an immediate impact on patient care and system improvements. The group members utilize national health services and administrative databases, as well as institutional databases, to investigate and to address factors contributing to disease outcomes and healthcare disparities.

<span class="mw-page-title-main">Arvinder Singh Soin</span> Indian hepatologists

Dr. Arvinder Singh Soin is the Chief Hepatobiliary and Liver Transplant Surgeon & Chairman of the Institute of Liver Transplantation and Regenerative Medicine, Medanta-The Medicity, India. A surgeon and pioneer in the field of liver transplantation, acknowledged for his work in establishing liver transplantation in India. Dr. Soin also runs the Liver Transplant institute at the Sir H. N. Reliance Foundation Hospital, Mumbai. Dr Soin has performed more than 3500 living donor liver transplants in India, which is the highest in the country, and the second-highest in the world.

Thomas D. Schiano, M.D., is an American specialist in liver transplantation, intestinal transplantation and in the diagnosis and treatment of acute and chronic liver disease. He serves as associate editor for the journals Hepatology and Liver Transplantation and has published more than 200 peer-reviewed articles and abstracts and more than 20 book chapters.

Bernd Schröppel is a German former transplant nephrologist at the Mount Sinai Medical Center and the former medical director of the kidney pancreas transplant program at the Recanati/Miller Transplantation Institute at the Mount Sinai Medical Center in New York City. He is also a former assistant professor of nephrology at the Mount Sinai School of Medicine.

<span class="mw-page-title-main">Subash Gupta</span>

Dr Subhash Gupta is the chief of liver transplantation, a hepato-pancreato-biliary surgeon, and the chairman of the Max Center of Liver and Biliary Sciences at Max Healthcare, Saket.

<span class="mw-page-title-main">Obeticholic acid</span> Chemical compound

Obeticholic acid (OCA), sold under the brand name Ocaliva, is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid. It is used as a medication used to treat primary biliary cholangitis. Intercept Pharmaceuticals Inc. hold the worldwide rights to develop OCA outside Japan and China, where it is licensed to Dainippon Sumitomo Pharma.

J. Michael Henderson is an American general and transplant surgeon, with experience in portal hypertension, liver transplantation, and pancreatic disease. Henderson is the Chief Medical Officer at the University of Mississippi Medical Center since 2015. Prior to this role, he was with the Cleveland Clinic from 1992–2014. He was the Chairman of the Department of General Surgery and Director of the Transplant Center for 12 years, and was the Chief Quality Officer for the Cleveland Clinic’s 10-hospital system for eight years.

<span class="mw-page-title-main">Intestine transplantation</span> Surgical replacement of the small intestine

Intestine transplantation is the surgical replacement of the small intestine for chronic and acute cases of intestinal failure. While intestinal failure can oftentimes be treated with alternative therapies such as parenteral nutrition (PN), complications such as PN-associated liver disease and short bowel syndrome may make transplantation the only viable option. One of the rarest type of organ transplantation performed, intestine transplantation is becoming increasingly prevalent as a therapeutic option due to improvements in immunosuppressive regimens, surgical technique, PN, and the clinical management of pre and post-transplant patients.

James Michael Millis is an American academic and surgeon specializing in pediatric and adult liver transplantation. He is Professor of Surgery and Vice Chair of Global Surgery at University of Chicago. He is also the director of Clinical Leadership Development Fellowship and Hepatobiliary Surgery at the University of Chicago Medical Center. He is known for developing new techniques of liver surgery that improved outcomes following liver transplantation and non transplant liver and biliary tract surgery.

References

  1. "American Society of Transplant Surgeons" . Retrieved 30 March 2010.
  2. "Sander Florman – research profile on BiomedExperts" . Retrieved 30 March 2010.[ permanent dead link ]
  3. "Top Doctors in Louisiana". New Orleans Magazine. Retrieved 30 March 2010.
  4. "CityBusiness to recognize 68 Health Care Heroes". 30 April 2007. Retrieved 30 March 2010.
  5. "40 Under 40". Gambit Weekly. Archived from the original on 7 July 2012. Retrieved 30 March 2010.
  6. "Louisiana's Top Doctors" . Retrieved 30 March 2010.
  7. "Tulane University". Archived from the original on 15 July 2011. Retrieved 30 March 2010.
  8. 1 2 "Tulane Surgical Society" . Retrieved 30 March 2010.[ permanent dead link ]
  9. ASTA Previous Grants & Award Recipients